CarbGen Co.
Latest round
- Series A
Last raised
- Jan 2023
Total raised
- $3.4M
Investors
- 1
About CarbGen Co.
, Ltd. operates as a biotechnology company that engages in the research and development of bacterial infectious diseases and drug resistance through bioinformatics and artificial technology. As of January 2023, Masakazu Nakajima serves as the CEO of the company., Ltd. The company provides products and services including point-of-care automatic Gram dyeing machines (POCGS); BiTTE, an app that aids in the selection of antibacterial medications by estimating the species of bacterial infections; medical image remote diagnosis support platform (CB Connect); microorganism observation smartphone adapter (AMO); specialised field consulting in infectious disease areas and business planning support services; and support services for specialists in infectious diseases and drug resistance issues. The business offers technology like the CBX-030A bacterial estimation and antibiotic suggestion system, the CBX-047A telediagnostic platform for medical images, the CBX-049A point-of-care gram stainer, and the CBX-048 adapter for microscopic inspection. CarbGen’s partners include Kobe University, Northwell Health Foundation, NCGM, and others.
Who invested in CarbGen Co.
1 investor across 1 round
See all investors in CarbGen Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 16, 2023
Amount
$3.4M
Investors
Questions about CarbGen Co.
Who invested in CarbGen Co.?
CarbGen Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CarbGen Co. raised?
CarbGen Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CarbGen Co. last raise money?
CarbGen Co.'s most recent round on record is a Series A, in Jan 2023.
What does CarbGen Co. do?
CarbGen Co. is a biotechnology company.
Where is CarbGen Co. headquartered?
CarbGen Co. is headquartered in Tokyo, Japan.
Which VCs invest in companies like CarbGen Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at CarbGen Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like CarbGen Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.